Funder
Health Research Council of New Zealand
University of Auckland
Subject
Cancer Research,Oncology,Epidemiology
Reference42 articles.
1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018
2. Lung cancer;Reckamp,2016
3. Treatment algorithms for patients with metastatic non-small cell, non squamous lung cancer;Melosky;Front. Oncol.,2014
4. Lynch J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib. N Engl J Med [Internet]. 2004 May 20 [cited 2018 May 18];350(21):2129–2139. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa040938.
5. First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung;Han;J. Clin. Oncol.,2012